Kenneth Galbraith, Zymeworks CEO

Up­dat­ed: Zymeworks want­ed a Big Phar­ma part­ner for its bis­pe­cif­ic. Jazz Phar­ma­ceu­ti­cals said OK

Speak­ing in a Star­bucks booth on the side­lines of AS­CO in June, Ken­neth Gal­braith em­pha­sized he want­ed what Dai­ichi Sankyo got for its HER2 break­out …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.